A biosensor based on magnetic microspheres functionalized with a DNA-aptamer was developed for the specific biomonitoring of biological contaminants (mycotoxins) in urine.
Technologies
In this section it is possible to view, also through targeted research, the technologies inserted in the PROMO-TT Database. For further information on the technologies and to contact the CNR Research Teams who developed them, it is necessary to contact the Project Manager (see the references at the bottom of each record card).
Displaying results 1 - 15 of 38
AIDD is an integrated tool and a radically new way to discovery new drugs for neurodegenerative diseases (Alzheimer’s, Epilepsy, Ageing, etc.).
Aliophen-XP is a highly concentrated polyphenolic composition derived from Aliophen®, a patented formulation based on malt and hops (Patent No. 102017000096298). Developed to enhance the original formulation, Aliophen-XP is produced through a specialized process that removes components potentially interfering with the biological activity of the bioactive compounds naturally extracted from malt and hops.
This innovative technology involves the use of a high-affinity, highly specific antibody that targets extracellular domains of connexin hemichannels (Cx26, Cx30, and Cx32). The antibody has been designed to reduce or inhibit the growth of brain tumors, particularly glioblastoma (GBM), and to alleviate the associated epilepsy. By blocking connexin hemichannels, the antibody interferes with pathological ATP release and other signaling mechanisms that contribute to tumor progression and neural hyperexcitability.
The proposed technology consists of a portable device for monitoring the freshness of fish, based on its smell. The device is based on a gas sensor and pattern recognition software to correlate the sensor signal to the freshness of the food. The technology is designed for its integration into domestic or industrial refrigerators.
B-ME developed the first thermoplastic composite electrode film based on bio-derived and biodegradable polyesters and carbon nano-fibers. It is metal-free, highly electrically conductive and possess good thermo-mechanical properties, a challenging combination of three features in a single product. This is the first-of-its-kind product, as, to the best of our knowledge, no thermoplastic biobased electrode film has been effectively produced and used so far.
A virtuous multi-step biorefinery platform to convert urban biowaste into valuable molecules, not disregarding renewable energy and digestate production. The strategy is based on the integration of a thermal pretreatment capable of significantly increasing the fraction of fermentable organic carbon, in order to furthermore change the status of the feedstock to become more suitable for production of a) high-value bio-based molecules, b) biomethane and c) hygienized digestate to be recycled as biofertilizer.
The final technology will add polarimetric capability to imaging cameras in the NUV/optical, providing simultaneous measurements of the different polarization states of the light. This will be obtained by the development of an innovative coating based on nanostructured emissive materials sensitive to the polarization of the incident light. A double layer film of two organic systems will be coupled to image detectors so that the two polarization components of the incoming light are converted into two different colors.
The present invention relates to a gamma camera for intracavitary use, which is widely used in the field of radio-guided surgery (intra-operative and laparoscopic and robotic-assisted) for the localisation of lymph nodes and tumours and/or other pathologies. The aim of the present invention is to make available an intraoperative tool able to overcome the drawbacks of the present known art.
Shape memory alloys (SMA) have attracted increasing interest in recent years as materials suitable for solid state refrigeration. One of the most attractive methods is mechanical deformation to induce the phase transformation and to generate and absorb heat through the elastocaloric effect.
Method for extracting, with high yield, phycobiliproteins from cyanobacterial and/or algal biomass, obtaining aqueous extracts characterized by high concentration of pigments (4-5 mg/mL) and a purity, at least equal to food/cosmetic grade (P≥2).
We propose an optical technique for the fast check of the presence, on the exposed surfaces of persons and objects, of explosives and their precursors, or drugs, or in general materials which are not allowed in restricted environments: airports, courts, places of worship, etc. The technique yields bi-dimensional pictures, with exposure time of < 1 sec, reporting the target substances, and their locations and quantities. The technique already provided laboratory preliminary results, to be completed, and fully validated for sensitivity and selectivity.
Inert biomedical devices with modular load-bearing function designed with peculiar multi-domain composite microstructures. The reference compositional system is Zirconia-Alumina with a prevailing overall composition of customizable zirconia or alumina. Examples of devices are 3D structures consisting of parts with differentiated functional properties, due to different composition/microstructure/architecture, and further functionalizable ex-post to favor and improve the stabilization of the implantation by newly formed bone in superior quantity and quality.
The proposed technology takes advantages of the huge potentialities of the gellan gum microgels in the preservation of cultural heritage. Microgels are polymeric gels particles with the micro and nanoscale size, whose soft nature is due to the presence of the aqueous solvent inside the particle. For their small size, they can easily diffuse in the environment and penetrate in the porous structure of paper and wood to act as cleaner agent.
22q11.2DS(DGS) deletion syndrome is a rare and phenotypically variable multiorgan syndrome, currently without any cure. Our aim is to develop a standardized approach to formulate pharmacological products useful for clinical trials direct to prevent some serious clinical manifestations of adolescence and adulthood, such as neuropsychiatric and musculoskeletal diseases, or to eliminate or improve cardiovascular defects during embryonic development.